Alvotech (ALVO) Share-based Compensation (2021 - 2026)
Alvotech's (ALVO) quarterly Share-based Compensation came in at $2.3 million in Q1 2026, up 79.2% YoY from $1.3 million in Q1 2025, and up 566.0% on a QoQ basis from -$503000.0 in Q4 2025.
Alvotech (ALVO) Share-based Compensation (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Share-based Compensation data on file, last reported at $2.3 million in Q1 2026.
- Quarterly Share-based Compensation rose 79.2% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (up 37.8% YoY) and the FY2025 annual result came in at $7.4 million, down 3.25% from the prior year.
- Share-based Compensation advanced to $2.3 million in Q1 2026, from -$503000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $6.4 million in Q1 2023 to a low of -$503000.0 in Q4 2025.
- A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 253.95% — and 2024, when it slumped 109.0%.
- Tracing ALVO's Share-based Compensation over 5 years: stood at $4.6 million in 2022, then slumped by 38.8% to $2.8 million in 2023, then slumped by 109.0% to -$255000.0 in 2024, then sank by 97.25% to -$503000.0 in 2025, then jumped by 566.0% to $2.3 million in 2026.
- The last three Share-based Compensation figures came in at $2.3 million (Q1 2026), -$503000.0 (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -503,000.00 |
| Dec 31, 2025 | -503,000.00 |
| Sep 30, 2025 | 4.46 Mn |
| Sep 30, 2025 | 4.46 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Mar 31, 2025 | 1.31 Mn |
| Dec 31, 2024 | -255,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 2.83 Mn |
| Dec 31, 2023 | 2.83 Mn |